Found: 29
Select item for more details and to access through your institution.
Heterodimeric Radiotracer Targeting PSMA and GRPR for Imaging of Prostate Cancer—Optimization of the Affinity towards PSMA by Linker Modification in Murine Model.
- Published in:
- Pharmaceutics, 2020, v. 12, n. 7, p. 614, doi. 10.3390/pharmaceutics12070614
- By:
- Publication type:
- Article
Evaluation of Tumor-Targeting Properties of an Antagonistic Bombesin Analogue RM26 Conjugated with a Non-Residualizing Radioiodine Label Comparison with a Radiometal-Labelled Counterpart.
- Published in:
- Pharmaceutics, 2019, v. 11, n. 8, p. 380, doi. 10.3390/pharmaceutics11080380
- By:
- Publication type:
- Article
Synthesis and Preclinical Evaluation of Radio-Iodinated GRPR/PSMA Bispecific Heterodimers for the Theranostics Application in Prostate Cancer.
- Published in:
- Pharmaceutics, 2019, v. 11, n. 7, p. 358, doi. 10.3390/pharmaceutics11070358
- By:
- Publication type:
- Article
Comparative Evaluation of Radioiodine and Technetium-Labeled DARPin 9_29 for Radionuclide Molecular Imaging of HER2 Expression in Malignant Tumors.
- Published in:
- Contrast Media & Molecular Imaging, 2018, p. 1, doi. 10.1155/2018/6930425
- By:
- Publication type:
- Article
High Contrast PET Imaging of GRPR Expression in Prostate Cancer Using Cobalt-Labeled Bombesin Antagonist RM26.
- Published in:
- Contrast Media & Molecular Imaging, 2017, v. 2017, p. 1, doi. 10.1155/2017/6873684
- By:
- Publication type:
- Article
Benefit of Later-Time-Point PET Imaging of HER3 Expression Using Optimized Radiocobalt-Labeled Affibody Molecules.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 6, p. 1972, doi. 10.3390/ijms21061972
- By:
- Publication type:
- Article
Molecular Design of HER3-Targeting Affibody Molecules: Influence of Chelator and Presence of HEHEHE-Tag on Biodistribution of 68Ga-Labeled Tracers.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 5, p. 1080, doi. 10.3390/ijms20051080
- By:
- Publication type:
- Article
Imaging of fibrogenesis in the liver by [<sup>18</sup>F]TZ-Z09591, an Affibody molecule targeting platelet derived growth factor receptor β.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00210-6
- By:
- Publication type:
- Article
In vivo evaluation of a novel format of a bivalent HER3-targeting and albumin-binding therapeutic affibody construct.
- Published in:
- Scientific Reports, 2017, p. 43118, doi. 10.1038/srep43118
- By:
- Publication type:
- Article
Influence of composition of cysteine-containing peptide-based chelators on biodistribution of <sup>99m</sup>Tc-labeled anti-EGFR affibody molecules.
- Published in:
- Amino Acids, 2018, v. 50, n. 8, p. 981, doi. 10.1007/s00726-018-2571-1
- By:
- Publication type:
- Article
Evaluation of Tc-Z-GGGC affibody molecule, a new probe for imaging of insulin-like growth factor type 1 receptor expression.
- Published in:
- Amino Acids, 2015, v. 47, n. 2, p. 303, doi. 10.1007/s00726-014-1859-z
- By:
- Publication type:
- Article
Synthesis of <sup>11</sup>C‐labeled Sulfonyl Carbamates through a Multicomponent Reaction Employing Sulfonyl Azides, Alcohols, and [<sup>11</sup>C]CO.
- Published in:
- ChemistryOpen, 2016, v. 5, n. 6, p. 566, doi. 10.1002/open.201600091
- By:
- Publication type:
- Article
Bispecific GRPR-Antagonistic Anti-PSMA/GRPR Heterodimer for PET and SPECT Diagnostic Imaging of Prostate Cancer.
- Published in:
- Cancers, 2019, v. 11, n. 9, p. 1371, doi. 10.3390/cancers11091371
- By:
- Publication type:
- Article
Increase in negative charge of <sup>68</sup>Ga/chelator complex reduces unspecific hepatic uptake but does not improve imaging properties of HER3-targeting affibody molecules.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-54149-3
- By:
- Publication type:
- Article
Selection of an optimal macrocyclic chelator improves the imaging of prostate cancer using cobalt-labeled GRPR antagonist RM26.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-52914-y
- By:
- Publication type:
- Article
Improved contrast of affibody-mediated imaging of HER3 expression in mouse xenograft model through co-injection of a trivalent affibody for in vivo blocking of hepatic uptake.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-43145-2
- By:
- Publication type:
- Article
Radionuclide Therapy of HER2-Expressing Human Xenografts Using Affibody-Based Peptide Nucleic Acid--Mediated Pretargeting: In Vivo Proof of Principle.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 7, p. 1092, doi. 10.2967/jnumed.118.208348
- By:
- Publication type:
- Article
Radionuclide Tumor Targeting Using ADAPT Scaffold Proteins: Aspects of Label Positioning and Residualizing Properties of the Label.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 1, p. 93, doi. 10.2967/jnumed.117.197202
- By:
- Publication type:
- Article
Feasibility of Affibody-Based Bioorthogonal Chemistry-Mediated Radionuclide Pretarge.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 3, p. 431, doi. 10.2967/jnumed.115.162248
- By:
- Publication type:
- Article
Comparison of tumor-targeting properties of directly and indirectly radioiodinated designed ankyrin repeat protein (DARPin) G3 variants for molecular imaging of HER2.
- Published in:
- International Journal of Oncology, 2019, v. 54, n. 4, p. 1209
- By:
- Publication type:
- Article
Evaluation of a radiocobalt-labelled affibody molecule for imaging of human epidermal growth factor receptor 3 expression.
- Published in:
- International Journal of Oncology, 2017, v. 51, n. 6, p. 1765, doi. 10.3892/ijo.2017.4152
- By:
- Publication type:
- Article
Feasibility of imaging of epidermal growth factor receptor expression with ZEGFR:2377 affibody molecule labeled with <sup>99m</sup>Tc using a peptide-based cysteine-containing chelator.
- Published in:
- International Journal of Oncology, 2016, v. 49, n. 6, p. 2285, doi. 10.3892/ijo.2016.3721
- By:
- Publication type:
- Article
Selection of optimal chelator improves the contrast of GRPR imaging using bombesin analogue RM26.
- Published in:
- International Journal of Oncology, 2016, v. 48, n. 5, p. 2124, doi. 10.3892/ijo.2016.3429
- By:
- Publication type:
- Article
PET imaging of epidermal growth factor receptor expression in tumours using <sup>89</sup>Zr-labelled ZEGFR:2377 affibody molecules.
- Published in:
- International Journal of Oncology, 2016, v. 48, n. 4, p. 1325, doi. 10.3892/ijo.2016.3369
- By:
- Publication type:
- Article
Trastuzumab cotreatment improves survival of mice with PC‐3 prostate cancer xenografts treated with the GRPR antagonist <sup>177</sup>Lu‐DOTAGA‐PEG<sub>2</sub>‐RM26.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 12, p. 3347, doi. 10.1002/ijc.32401
- By:
- Publication type:
- Article
Preclinical Evaluation of the Copper-64 Labeled GRPR-Antagonist RM26 in Comparison with the Cobalt-55 Labeled Counterpart for PET-Imaging of Prostate Cancer.
- Published in:
- Molecules, 2020, v. 25, n. 24, p. 5993, doi. 10.3390/molecules25245993
- By:
- Publication type:
- Article
The Effect of Mini-PEG-Based Spacer Length on Binding and Pharmacokinetic Properties of a <sup>68</sup>Ga-Labeled NOTA-Conjugated Antagonistic Analog of Bombesin.
- Published in:
- Molecules, 2014, v. 19, n. 7, p. 10455, doi. 10.3390/molecules190710455
- By:
- Publication type:
- Article
Optimization of HER3 expression imaging using affibody molecules: Influence of chelator for labeling with indium-111.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-018-36827-w
- By:
- Publication type:
- Article
Affibody-mediated imaging of EGFR expression in prostate cancer using radiocobalt-labeled DOTA-Z<sub>EGFR:2377</sub>.
- Published in:
- Oncology Reports, 2019, v. 41, n. 1, p. 534, doi. 10.3892/or.2018.6792
- By:
- Publication type:
- Article